Onderneming Innovent Biologics, Inc. OTC Markets
Aandelen
IVBIY
US45783L1017
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19,48 USD | +4,39% | -.--% | -6,75% |
Vakgebied
Aantal werknemers: 4 872
Verkoop per activiteit
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development
100,0
%
| 5 299 | 100,0 % | 6 858 | 100,0 % | +29,43% |
Verkoop per regio
HKD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
92,7
%
| 4 806 | 90,7 % | 6 357 | 92,7 % | +32,29% |
United States
7,1
%
| 478 | 9,0 % | 489 | 7,1 % | +2,32% |
Others
0,2
%
| 15 | 0,3 % | 11 | 0,2 % | -24,88% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
De Chao Yu
CEO | Chief Executive Officer | 61 | 28-04-11 |
Fei You
DFI | Director of Finance/CFO | 45 | 05/02 |
Yong-Jun Liu
PSD | President | - | 15-10-20 |
Ghang Shou Gao
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-20 |
Qin Wei Zhou
COO | Chief Operating Officer | 61 | 16-06-16 |
Hao Xi Ede
BRD | Director/Board Member | 65 | 05-06-17 |
Vivian Zhang
HRO | Human Resources Officer | - | 01-03-12 |
Blake Salisbury
PRN | Corporate Officer/Principal | - | 01-03-16 |
Yan Ju Wang
SEC | Corporate Secretary | 36 | 01-10-15 |
Lok Yee Chan
SEC | Corporate Secretary | 35 | 04-06-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Zieziula
BRD | Director/Board Member | 69 | 31-05-22 |
Charles Cooney
BRD | Director/Board Member | 80 | 18-10-15 |
De Chao Yu
CEO | Chief Executive Officer | 61 | 28-04-11 |
I Yin Hsu
BRD | Director/Board Member | 50 | 18-10-18 |
Hao Xi Ede
BRD | Director/Board Member | 65 | 05-06-17 |
Kai Xian Chen
BRD | Director/Board Member | 78 | 18-10-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 627 101 801 | 1 512 334 602 ( 92,95 %) | 0 | 92,95 % |
Bedrijfsgegevens
Innovent Biologics, Inc.
168 Dongping Street Suzhou Industrial Park
215123, Suzhou
+86 512 6956 6088
http://www.innoventbio.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,39% | 92,59 mld. | |
+3,16% | 41,43 mld. | |
-11,10% | 33,49 mld. | |
+53,99% | 25,06 mld. | |
-9,41% | 12,77 mld. | |
-12,25% | 11,58 mld. | |
-44,00% | 11,35 mld. | |
+5,77% | 8,97 mld. | |
-7,11% | 7,02 mld. |
- Beurs
- Aandelen
- Koers 1801
- Koers IVBIY
- Onderneming Innovent Biologics, Inc.